← Back
$LYEL All transactions

Lyell Immunopharma, Inc.

▼ SELL

$ Value

$15K

Shares

1,453

Price

$11

Filed

Aug 22

Insider

Name

Newton Charles W.

Title

Chief Financial Officer

CIK

0001866219

Roles

Officer

Transaction Details

Transaction Date

2025-08-21

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

15,306

Footnotes

Pursuant to performance-based restricted stock units granted to the reporting person on February 9, 2024, 4,000 shares were issued on the Transaction Date upon the achievement of certain performance criteria certified by the compensation committee of the Issuer's board of directors on the Transaction Date and 4,000 shares will be issued on August 20, 2026, subject to the reporting person providing service through such date. | Shares automatically sold to cover tax withholding obligation from settlement of vested restricted stock units. | The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $10.49 to $10.64 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. | Shares held by The Charles & Lisa Newton Living Trust. The Reporting Person is co-trustee and co-grantor of The Charles & Lisa Newton Living Trust.

Filing Info

Accession No.

0001415889-25-022741

Form Type

4

Issuer CIK

0001806952

Newton Charles W.'s History

Date Ticker Type Value
2025-08-21 LYEL $15K
2025-08-20 LYEL A $0
2025-08-12 LYEL $1K
2025-08-11 LYEL $1K
2025-06-12 CHRS A $0
2025-05-13 TSVT D
2025-05-13 TSVT U
2025-05-13 TSVT D
2025-05-13 TSVT D
2025-04-25 NVAX A $0

Other Insiders at LYEL (90d)

No other insider activity at this issuer in the last 90 days.